Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Index
-
Market Cap
11.95B
Enterprise Value
15.57B
Income
476.91M
Sales
7.12B
Book/sh
10.96
Cash/sh
4.91
Employees
63388
IPO
Nov 18, 1996
P/E
25.25
Forward P/E
15.69
PEG
1.74
P/S
1.68
P/B
2.17
P/C
4.84
P/FCF
15.55
EV/EBITDA
9.40
EV/Sales
2.19
Quick Ratio
0.98
Current Ratio
1.06
Debt/Eq
1.10
LT Debt/Eq
0.72
Option/Short
Yes / Yes
EPS (ttm)
0.94
EPS next Y
1.51
EPS next Q
0.65
EPS this Y
8.85%
EPS next Y
7.77%
EPS next 5Y
9.03%
EPS past 3/5Y
9.35% 7.73%
Sales past 3/5Y
14.81% 14.12%
EPS Y/Y TTM
43.13%
Sales Y/Y TTM
2.92%
EPS Q/Q
3.18%
Sales Q/Q
5.76%
Insider Own
0.00%
Insider Trans
-
Inst Own
16.67%
Inst Trans
7.26%
ROA
2.23%
ROE
5.96%
ROIC
5.02%
Gross Margin
13.95%
Oper. Margin
13.95%
Profit Margin
6.70%
SMA20
4.76%
SMA50
8.29%
SMA200
-15.60%
Trades
Shs Outstand
503.54M
Shs Float
503.54M
52W High
34.67 -31.52%
52W Low
19.50 21.77%
Volatility
1.65% 1.68%
ATR (14)
0.50
RSI (14)
63.16
Beta
1.00
Rel Volume
0.00
Avg Volume
1.74M
Volume
0
Perf Week
0.72%
Perf Month
17.18%
Perf Quarter
-2.63%
Perf Half Y
-27.47%
Perf YTD
-19.42%
Perf Year
-13.29%
Perf 3Y
-13.14%
Perf 5Y
-43.41%
Perf 10Y
72.10%
Prev Close
23.74
Price
23.74
Change %
0.00%
Consensus
Buy
Avg. Price Target
$29.11
Implied Upside
+22.6%
Analysts12incl. previous ratings
Rating Distribution5 Buy · 7 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Oct 05, 2026Upgrade
SF logoSStifel
Hold → Buy
Sep 29, 2026Downgrade
MS logoMMorgan Stanley
Overweight → Equal-Weight
Jul 31, 2026Downgrade
BBNP Paribas Exane
Outperform → Neutral$26.70+12.5%
Jul 07, 2026Upgrade
GS logoGGoldman
Neutral → Buy
Mar 12, 2026Upgrade
UBS logoUUBS
Neutral → Buy
Mar 11, 2026Upgrade
RRothschild & Co Redburn
Sell → Neutral
Feb 24, 2026Downgrade
DB logoDDeutsche Bank
Buy → Hold
Jan 06, 2026Upgrade
MS logoMMorgan Stanley
Equal-Weight → Overweight
Dec 18, 2025Upgrade
BAC logoBBofA Securities
Neutral → Buy$34+43.2%
Oct 07, 2025Upgrade
BBernstein
Underperform → Outperform
Rentokil Initial Plc engages in the provision of business support services. The firm's products and services protect people from pest-borne disease and the risks of poor hygiene. It operates through the following geographical segments: North America, Europe, UK and Sub-Saharan Africa, Asia and MENAT, and Pacific. The company was founded by Harold Maxwell-Lefroy on September 24, 1924 and is headquartered in Crawley, the United Kingdom.
CFO & DirectorMr. Paul Russell Edgecliffe-Johnson
CEO & Executive DirectorMr. Michael A. Duffy Jr.
Chief Information OfficerMr. Mark Purcell
Head of Investor RelationsMs. Heather Wood
General Counsel & Company SecretaryMs. Rachel Eleanor Canham